Journal of Shandong University (Health Sciences) ›› 2021, Vol. 59 ›› Issue (8): 80-85.doi: 10.6040/j.issn.1671-7554.0.2021.0440

Previous Articles     Next Articles

Effects of valproic acid on the survival and tumor recurrence of 134 patients with glioma treated with radiotherapy

SUN Qingjie1, ZHANG Yisha1, GUAN Shanghui2, FENG Zhihui1   

  1. 1. Department of Occupational and Environmental Health, School of Public Health, Shandong University, Jinan 250012, Shandong, China;
    2. Department of Oncology, Qilu Hospital of Shandong University, Jinan 250012, Shandong, China
  • Published:2021-09-16

PDF (PC)

191

Abstract: Objective To analyze the effects of valproic acid(VPA)on the prognostic survival and tumor recurrence of patients with glioma treated with radiotherapy, so as to provide a clinical basis for the study of the effect of VPA on enhancing the inhibition of tumor growth by radiation and prolonging the survival time of patients. Methods The clinical and follow-up data of 134 glioma patients who underwent surgery and radiotherapy in the Oncology Department of Qilu Hospital, Shandong University during 2012 and 2016 were retrospectively analyzed. The effects of VPA on overall survival(OS)and progression-free survival(PFS)were analyzed with multivariate Cox proportional hazard model. Results The median OS and PFS were 49 and 52 months, respectively. Univariate analysis showed VPA, pathological grade, age and chemotherapy were associated with the prognosis(P<0.05). Multivariate analysis showed, after adjustment of age, pathological grade and the effects of chemotherapy, VPA improved the OS(HR=0.49, 95%CI: 0.30-0.80)and PFS(HR=0.56, 95%CI: 0.33-0.93). Conclusion VPA can significantly prolong the survival time of patients with glioma and reduce tumor recurrence.

Key words: Glioma, Valproic acid, Overall survival, Progression-free survival

CLC Number: 

  • R730.7
[1] Zhang X, Yang H, Gong B, et al. Combined gene expression and protein interaction analysis of dynamic modularity in glioma prognosis [J]. J Neurooncol, 2012, 107(2): 281-288.
[2] Watanabe S, Kuwabara Y, Suehiro S, et al. Valproic acid reduces hair loss and improves survival in patients receiving temozolomide-based radiation therapy for high-grade glioma [J]. Eur J Clin Pharmacol, 2017, 73(3): 357-363.
[3] Saeed H, Tseng YD, Lo SS. Narrative review of palliative hypofractionated radiotherapy for high grade glioma [J]. Ann Palliat Med, 2021, 10(1): 846-862.
[4] Majchrzak K, Kaspera W, Bobek-Billewicz B, et al. The assessment of prognostic factors in surgical treatment of low-grade gliomas: a prospective study [J]. Clin Neurol Neurosurg, 2012, 114(8): 1135-1144.
[5] Jiang T, Mao Y, Ma W, et al. CGCG clinical practice guidelines for the management of adult diffuse gliomas [J]. Cancer Lett, 2016, 375(2): 263-273.
[6] Liang J, Zhang X, Xie S, et al. Ubiquitin-specific protease 22: a novel molecular biomarker in glioma prognosis and therapeutics[J]. Med Oncol, 2014, 31(4): 899.
[7] Yamaguchi S, Kobayashi H, Terasaka S, et al. The impact of extent of resection and histological subtype on the outcome of adult patients with high-grade gliomas [J]. Jpn J Clin Oncol, 2012, 42(4): 270-277.
[8] Turkoglu E, Gurer B, Sanli AM, et al. Clinical outcome of surgically treated low-grade gliomas: a retrospective analysis of a single institute [J]. Clin Neurol Neurosurg, 2013, 115(12): 2508-2513.
[9] Sun Y, Xiong ZY, Yan PF, et al. Characteristics and prognostic factors of age-stratified high-grade intracranial glioma patients: a population-based analysis [J]. Bosn J Basic Med Sci, 2019, 19(4): 375-383.
[10] Niu X, Wang T, Li J, et al. An integrative survival analysis with identification of prognostic factors in the patients with coexisting glioma and intracranial aneurysm[J]. World Neurosurg, 2018, 111: e592-e600. doi: 10.1016/j.wneu.2017.12.126
[11] Li J, Niu X, Gan Y, et al. Clinical and pathologic features and prognostic factors for recurrent gliomas [J]. World Neurosurg, 2019, 128: e21-e30. doi: 10.1016/j.wneu.2019.02.210.
[12] Choi J, Kim SH, Ahn SS, et al. Extent of resection and molecular pathologic subtype are potent prognostic factors of adult WHO grade II glioma [J]. Sci Rep, 2020, 10(1): 2086.
[13] Eckert M, Klumpp L, Huber SM. Cellular effects of the antiepileptic drug valproic acid in glioblastoma [J]. Cell Physiol Biochem, 2017, 44(4): 1591-1605.
[14] Hoja S, Schulze M, Rehli M, et al. Molecular dissection of the valproic acid effects on glioma cells [J]. Oncotarget, 2016, 7(39): 62989-63002.
[15] Guthrie GD, Eljamel S. Impact of particular antiepileptic drugs on the survival of patients with glioblastoma multiforme [J]. J Neurosurg, 2013, 118(4): 859-865.
[16] Luo Y, Wang H, Zhao X, et al. Valproic acid causes radiosensitivity of breast cancer cells via disrupting the DNA repair pathway [J]. Toxicol Res(Camb), 2016, 5(3): 859-870.
[17] Romain B, Benbrika-Nehmar R, Marisa L, et al. Histone hypoacetylation contributes to CXCL12 downregulation in colon cancer: impact on tumor growth and cell migration [J]. Oncotarget, 2017, 8(24): 38351-38366.
[18] Liu G, Wang H, Zhang F, et al. The effect of VPA on increasing radiosensitivity in osteosarcoma cells and primary-culture cells from chemical carcinogen-induced breast cancer in rats [J]. Int J Mol Sci, 2017, 18(5):1027. doi: 10.3390/ijms18051027.
[19] Shoji M, Ninomiya I, Makino I, et al. Valproic acid, a histone deacetylase inhibitor, enhances radiosensitivity in esophageal squamous cell carcinoma [J]. Int J Oncol, 2012, 40(6): 2140-2146.
[20] Sun L, He Q, Tsai C, et al. HDAC inhibitors suppressed small cell lung cancer cell growth and enhanced the suppressive effects of receptor-targeting cytotoxins via upregulating somatostatin receptor II [J]. Am J Transl Res, 2018, 10(2): 545-553.
[21] Sanaei M, Kavoosi F, Roustazadeh A, et al. In vitro effect of the histone deacetylase inhibitor valproic acid on viability and apoptosis of the PLC/PRF5 human hepatocellular carcinoma cell line [J].Asian Pac J Cancer Prev, 2018, 19(9): 2507-2510.
[22] Riva G, Cilibrasi C, Bazzoni R, et al. Valproic acid inhibits proliferation and reduces invasiveness in glioma stem cells through wnt/β catenin signalling activation [J]. Genes(Basel), 2018, 9(11): 522. doi: 10.3390/genes9110522.
[23] Liu G, Lim D, Cai Z, et al. The valproate mediates radio-bidirectional regulation through RFWD3-dependent ubiquitination on rad51 [J]. Front Oncol, 2021, 11: 646256. doi: 10.3389/fonc.2021.646256.
[24] Cai Z, Lim D, Liu G, et al. Valproic acid-like compounds enhance and prolong the radiotherapy effect on breast cancer by activating and maintaining anti-tumor immune function [J]. Front Immunol, 2021, 12: 646384. doi: 10.3389/fimmu.2021.646384.
[25] Terranova-Barberio M, Roca MS, Zotti AI, et al. Valproic acid potentiates the anticancer activity of capecitabine in vitro and in vivo in breast cancer models via induction of thymidine phosphorylase expression [J]. Oncotarget, 2016, 7(7): 7715-7731.
[26] Ryu CH, Yoon WS, Park KY, et al. Valproic acid downregulates the expression of MGMT and sensitizes temozolomide-resistant glioma cells [J]. J Biomed Biotechnol, 2012, 2012: 987495. doi: 10.1155/2012/987495.
[27] Plazibat M, Katuši c Bojanac A, Himerleich Peri c M, et al. Embryo-derived teratoma in vitro biological system reveals antitumor and embryotoxic activity of valproate [J]. FEBS J, 2020, 287(21): 4783-4800.
[28] Abaza MS, Bahman AM, Al-Attiyah RJ. Valproic acid, an anti-epileptic drug and a histone deacetylase inhibitor, in combination with proteasome inhibitors exerts antiproliferative, pro-apoptotic and chemosensitizing effects in human colorectal cancer cells: underlying molecular mechanisms [J]. Int J Mol Med, 2014, 34(2): 513-532.
[29] Peng J, Cai Z, Zhao R, et al. The intervention of valproic acid on the tumorigenesis induced by an environmental carcinogen of PAHs [J]. Toxicol Res(Camb), 2020, 9(5): 609-621.
[30] Luo Z, Wang Z, He X, et al. Effects of histone deacetylase inhibitors on regenerative cell responses in human dental pulp cells[J]. Int Endod J, 2018,51(7):767-778.
[31] Tian Y, Liu G, Wang H, et al. Valproic acid sensitizes breast cancer cells to hydroxyurea through inhibiting RPA2 hyperphosphorylation-mediated DNA repair pathway[J]. DNA Repair(Amst), 2017, 58: 1-12. doi: 10.1016/j.dnarep.2017.08.002.
[32] Redjal N, Reinshagen C, Le A, et al. Valproic acid, compared to other antiepileptic drugs, is associated with improved overall and progression-free survival in glioblastoma but worse outcome in grade Ⅱ/Ⅲ gliomas treated with temozolomide[J]. J Neuro-Oncol, 2016, 127(3): 505-514.
[1] WANG Lin-Lin, SUN Mei-Li, SUN Yu-Ping, ZHANG Nan, LIU Chuan-Yong. Expressions of α-Tubulin and γ-Tubulin in human Glioma and their relation with Survivin [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 103-.
[2] GU Jinhai, LU Ning, GU Jiarong, WEN Yujun, QIANG Yuanyuan, HE Zhenquan, YANG Yong, WANG Feng, SUN Tao, NIU Jianguo. Effects of signal Crosstalk between glioma cells and vascular endothelial cells on the proliferation and invasion of glioma cells [J]. Journal of Shandong University (Health Sciences), 2021, 59(2): 1-6.
[3] SONG Zhenzhen, SUN Xiaoling, LI Haiou, WANG Fang, ZHANG Ran, YU Dexin. Value of MRI radiomics of glioma and peritumoral edema in evaluating tumor recurrence [J]. Journal of Shandong University (Health Sciences), 2021, 59(11): 53-60.
[4] CHAI Xiaoxue, YE Hui, LYU Xinran, DING Xuchao, ZHEN Qiulai, DU Juan, CAO Lili. Prognostic value of POU4F3 in 118 patients with lung adenocarcinoma and its effect on migration of lung adenocarcinoma cells [J]. Journal of Shandong University (Health Sciences), 2021, 59(11): 8-18.
[5] LI Wenqing, YE Lan, JIANG Yuhua. CDK7 inhibitor THZ1 increases the radiosensitivity of human glioma cell line U251 [J]. Journal of Shandong University (Health Sciences), 2021, 59(1): 8-13.
[6] Qiang WU,Zekun HE,Ju LIU,Xiaomeng CUI,Shuang SUN,Wei SHI. A research on multi-modal MRI analysis based on machine learning for brain glioma [J]. Journal of Shandong University (Health Sciences), 2020, 1(8): 81-87.
[7] Tao JIANG. The application of brain-like intelligence in the frontiers of brain science [J]. Journal of Shandong University (Health Sciences), 2020, 1(8): 10-13.
[8] Anjing CHEN,Xun ZHANG. The new strategies of targeting SUMOylation in the treatment of glioma [J]. Journal of Shandong University (Health Sciences), 2020, 1(8): 88-94.
[9] Gang LI,Hao XUE,Wei QIU,Rongrong ZHAO. Research advances in the formation of glioma immunosuppressive microenvironment [J]. Journal of Shandong University (Health Sciences), 2020, 1(8): 67-73.
[10] XU Jixi, CHEN Weijian. Diffuse midline glioma with H3 K27M mutation in the spinal cord: a case report [J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 96-101.
[11] WANG Zhendong, DING Wenwen, FENG Zhihui. Correlation between valproic acid exposure and cancer risk in epileptic population [J]. Journal of Shandong University (Health Sciences), 2020, 58(4): 110-117.
[12] LI Hongyan, FANG Lei, ZHANG Hongying, SU Yuan, LI Ling. A clinical study of 5 cases of leucine-rich glioma inactivated 1 protein antibody associated limbic encephalitis [J]. Journal of Shandong University (Health Sciences), 2019, 57(5): 105-109.
[13] ZHAO Xueying, FAN Mingde, DONG Wenyan, QI Yingzhi, LU Xin. Expression and clinical significance of tripartite motif protein 26 in glioma tissues [J]. Journal of Shandong University (Health Sciences), 2019, 57(3): 63-68.
[14] LI Jie, HE Dong, ZHANG Rui, YANG Fan, FENG Shaobin, YANG Yihang, XIN Tao. Expression of karyopherin α2 and its effect on the biological behaviors of glioma [J]. Journal of Shandong University (Health Sciences), 2018, 56(12): 47-54.
[15] NIE Siyue, WANG Zhen, SUN Jingyu, LIU Jie, LI Juan, WEI Xiaojuan, LU Chunxiao, L(¨overU)Xingyan, WANG Shuyun, SUN Yuping. Expression and clinical significance of angiopoietin-like protein 5 in human gastric cancer tissues [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(8): 61-65.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] ZHENG Min,HAO Yue-wei,LIU Xue-ping,ZHAO Ting-ting. Relationship between the HPA-2 and Kozak sequence polymorphism of platelet membrane glycoprotein and cerebral infarction[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2008, 46(3): 292 -295 .
[2] ZHANG Jie,LI Zhen-hua,SUN Jin-hao,BAO Li-hua,LIU Yue-peng. Protective effects of the invariable magnetic field on oxidative injured Schwann cells[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2007, 45(3): 229 -232 .
[3] . [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2007, 45(10): 995 .
[4] JIANG Hong-ju,LI Run-zhi, WANG Ying,XU Dong-mei,ZHANG Mei,ZHANG Yun,LI Ji-fu. Relationship between the plasma level of matrix metalloproteinase-9 and structural characteristics of plaques and percutaneous coronary intervention [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2008, 46(10): 966 -970 .
[5] . [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2008, 46(8): 828 -830 .
[6] . [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2009, 47(9): 5 -6 .
[7] NIU Rui,LIU Bo,SHAO Ming-ju,WANG Wei. mRNA expression of lunx in regional lymph nodes of non-small cell lung cancer and its correlation with prognosis[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2007, 45(9): 884 -885 .
[8] WANG Shu-qin,QI Feng,WU Jian-bo,SUN Bao-zhu. Effect of calcium in ropivacaine-induced smooth muscle contraction of the aorta in rats in vitro[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2008, 46(8): 773 -776 .
[9] TENG Xue-ren,ZHAO Yong-sheng,HU Guang-liang,ZHOU Lun,LI Jian-min. Characteristics of microcosmic changes following tendon allograft transplantation preserved by two methods under light microscopy and transmission electron microscopy[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2008, 46(10): 945 -950 .
[10] WU Min,ZHAO Zhi-lun,WANG Jie-zhen. [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2006, 44(11): 1146 -1149 .
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd